IR News Archives
- Top
- Investor Relations
- IR News Archives
latest news
This is the archive of news updates from the Fuji Pharma website.
Click on each news item to view the full details.
latest news
- 2026.03.24
- Release(リリース)
- Fuji Pharma and Gedeon Richter Conclude Agreement for Joint Development Projects in Women's Health
- 2026.03.19
- Release(リリース)
- Notice Regarding Revision of Interim Dividend Forecasts for the Fiscal Year Ending September2026 (62ndFiscal Year)
- 2026.03.11
- Release(リリース)
- Notice Regarding Completion of Exercise of 2nd Series Stock Acquisition Rights Issued by Third-Party Allotment
- 2026.02.10
- Release(リリース)
- Notice of Application for Marketing Approval and Launch of Emergency Contraceptive Pill "LESOERU®72"
- 2026.02.05
- Financial Results(決算資料)
- Supplemental Materials of 1Q/FY2026 Consolidated Financial Results
- 2026.02.05
- Financial Results(決算資料)
- Notice Regarding Loss on Valuation of Securities for the First Quarter of the Fiscal Year ending September 2026
- 2026.01.30
- Release(リリース)
- Notice of Licensing and Settlement Regarding Aflibercept 2mg BS (Biosimilar)
- 2026.01.20
- Release(リリース)
- Marketing Approval for new specification of Ustekinumab Biosimilar ― USTEKINUMAB BS 90㎎ Syringe for S.C. Injection「F」―
- 2025.11.21
- Release(リリース)
- Notice of Additional Approval for the indication of NextstellisTM by OLIC (Thailand) Limited
- 2025.11.17
- Financial Results(決算資料)
- Script for Business Results Briefing for the Fiscal Year Ended September 30, 2025
- 2025.11.04
- Release(リリース)
- Notice of Settlement and License Agreement Regarding Golimumab BS (Biosimilar)
